Sign in

CIK 0001862150 · <br>Emerging growth company

Cingulate Inc.

Sign in to watch
Ticker
CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863825535
Phone
(913) 942-2300
Business address
1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Former names
Cingulate Inc.

Securities

  • CING Common Stock Nasdaq
  • CINGW Warrants Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-08-15 Myers Laurie EVP and COO Sale −202 $4.17 $841 0
2022-05-06 Medeiros Curtis Director Sale −17,532 $1.27 $22K 0

Page 1 of 1 · 2 trades